Suppr超能文献

加强以患者为中心的药物研发:将热熔挤出与熔融沉积建模以及压力辅助微注射器增材制造平台相结合,并采用质量源于设计理念。

Enhancing Patient-Centric Drug Development: Coupling Hot Melt Extrusion with Fused Deposition Modeling and Pressure-Assisted Microsyringe Additive Manufacturing Platforms with Quality by Design.

作者信息

Nyavanandi Dinesh, Mandati Preethi, Vidiyala Nithin, Parupathi Prashanth, Kolimi Praveen, Mamidi Hemanth Kumar

机构信息

Small Molecule Drug Product Development, Cerevel Therapeutics, Cambridge, MA 02141, USA.

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.

出版信息

Pharmaceutics. 2024 Dec 25;17(1):14. doi: 10.3390/pharmaceutics17010014.

Abstract

In recent years, with the increasing patient population, the need for complex and patient-centric medications has increased enormously. Traditional manufacturing techniques such as direct blending, high shear granulation, and dry granulation can be used to develop simple solid oral medications. However, it is well known that "one size fits all" is not true for pharmaceutical medicines. Depending on the age, sex, and disease state, each patient might need a different dose, combination of medicines, and drug release pattern from the medications. By employing traditional practices, developing patient-centric medications remains challenging and unaddressed. Over the last few years, much research has been conducted exploring various additive manufacturing techniques for developing on-demand, complex, and patient-centric medications. Among all the techniques, nozzle-based additive manufacturing platforms such as pressure-assisted microsyringe (PAM) and fused deposition modeling (FDM) have been investigated thoroughly to develop various medications. Both nozzle-based techniques involve the application of thermal energy. However, PAM can also be operated under ambient conditions to process semi-solid materials. Nozzle-based techniques can also be paired with the hot melt extrusion (HME) process for establishing a continuous manufacturing platform by employing various in-line process analytical technology (PAT) tools for monitoring critical process parameters (CPPs) and critical material attributes (CMAs) for delivering safe, efficacious, and quality medications to the patient population without compromising critical quality attributes (CQAs). This review covers an in-depth discussion of various critical parameters and their influence on product quality, along with a note on the continuous manufacturing process, quality by design, and future perspectives.

摘要

近年来,随着患者数量的增加,对复杂且以患者为中心的药物的需求大幅增长。传统制造技术,如直接混合、高剪切制粒和干法制粒,可用于开发简单的固体口服药物。然而,众所周知,药物并非“一刀切”。根据年龄、性别和疾病状态,每位患者可能需要不同的剂量、药物组合以及药物释放模式。采用传统方法开发以患者为中心的药物仍然具有挑战性且尚未得到解决。在过去几年中,已经开展了大量研究,探索各种增材制造技术来开发按需定制、复杂且以患者为中心的药物。在所有这些技术中,基于喷嘴的增材制造平台,如压力辅助微注射器(PAM)和熔融沉积建模(FDM),已被深入研究以开发各种药物。这两种基于喷嘴的技术都涉及热能的应用。然而,PAM也可以在环境条件下操作以处理半固体材料。基于喷嘴的技术还可以与热熔挤出(HME)工艺相结合,通过采用各种在线过程分析技术(PAT)工具来监测关键工艺参数(CPPs)和关键物料属性(CMAs),从而建立一个连续制造平台,以便在不影响关键质量属性(CQAs)的情况下,为患者群体提供安全、有效和高质量的药物。本综述深入讨论了各种关键参数及其对产品质量的影响,同时还介绍了连续制造工艺、设计质量以及未来展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5982/11769097/247d302714c9/pharmaceutics-17-00014-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验